BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 1372863)

  • 1. Molecular and biological properties of the vascular endothelial growth factor family of proteins.
    Ferrara N; Houck K; Jakeman L; Leung DW
    Endocr Rev; 1992 Feb; 13(1):18-32. PubMed ID: 1372863
    [No Abstract]   [Full Text] [Related]  

  • 2. The biology of vascular endothelial growth factor.
    Ferrara N; Davis-Smyth T
    Endocr Rev; 1997 Feb; 18(1):4-25. PubMed ID: 9034784
    [No Abstract]   [Full Text] [Related]  

  • 3. Double target for tumor mass destruction.
    Saharinen P; Alitalo K
    J Clin Invest; 2003 May; 111(9):1277-80. PubMed ID: 12727916
    [No Abstract]   [Full Text] [Related]  

  • 4. Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells.
    Ferrara N; Leung DW; Cachianes G; Winer J; Henzel WJ
    Methods Enzymol; 1991; 198():391-405. PubMed ID: 1857232
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor and its receptors is increased, but microvascular relaxation is impaired in patients after acute myocardial ischemia.
    Xu X; Li J; Simons M; Li J; Laham RJ; Sellke FW
    J Thorac Cardiovasc Surg; 2001 Apr; 121(4):735-42. PubMed ID: 11279416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.
    Houck KA; Leung DW; Rowland AM; Winer J; Ferrara N
    J Biol Chem; 1992 Dec; 267(36):26031-7. PubMed ID: 1464614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant.
    Whittle C; Gillespie K; Harrison R; Mathieson PW; Harper SJ
    Clin Sci (Lond); 1999 Sep; 97(3):303-12. PubMed ID: 10464055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.
    Myoken Y; Kayada Y; Okamoto T; Kan M; Sato GH; Sato JD
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5819-23. PubMed ID: 1712106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.
    He Y; Smith SK; Day KA; Clark DE; Licence DR; Charnock-Jones DS
    Mol Endocrinol; 1999 Apr; 13(4):537-45. PubMed ID: 10194760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biology of VEGF and its receptors.
    Ferrara N; Gerber HP; LeCouter J
    Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
    McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.
    Shweiki D; Itin A; Neufeld G; Gitay-Goren H; Keshet E
    J Clin Invest; 1993 May; 91(5):2235-43. PubMed ID: 7683699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.
    Houck KA; Ferrara N; Winer J; Cachianes G; Li B; Leung DW
    Mol Endocrinol; 1991 Dec; 5(12):1806-14. PubMed ID: 1791831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution.
    Pepper MS; Baetens D; Mandriota SJ; Di Sanza C; Oikemus S; Lane TF; Soriano JV; Montesano R; Iruela-Arispe ML
    Dev Dyn; 2000 Jul; 218(3):507-24. PubMed ID: 10878616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
    Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
    Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Still more debate over VEGF.
    Isner JM
    Nat Med; 2001 Jun; 7(6):639-41. PubMed ID: 11385475
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF) and its receptors in tumor-bearing dogs.
    Scheidegger P; Weiglhofer W; Suarez S; Kaser-Hotz B; Steiner R; Ballmer-Hofer K; Jaussi R
    Biol Chem; 1999 Dec; 380(12):1449-54. PubMed ID: 10661874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor.
    Marti HH
    Adv Exp Med Biol; 2002; 513():375-94. PubMed ID: 12575829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.